Review



primary antibodies rabbit monoclonal anti-muc2  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Santa Cruz Biotechnology primary antibodies rabbit monoclonal anti-muc2
    Primary Antibodies Rabbit Monoclonal Anti Muc2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+rabbit+anti-muc2/anti+gr/pm36603529-149-9-13
    Average 90 stars, based on 1 article reviews
    primary antibodies rabbit monoclonal anti-muc2 - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Vitamin B12 Deficiency Alters the Gut Microbiota in a Murine Model of Colitis
    Article Snippet: Briefly, colonic sections were incubated with primary rabbit anti-Muc2 (Santa-Cruz, Dallas, TX) overnight at 4°C followed by Alexa Fluor 488-conjugated secondary (Invitrogen, Carlsbad, CA) and DAPI (Vector Laboratories, Burlingame, CA) at room temperature for 2 hours.



    Similar Products

    90
    Abbexa Ltd primary antibody rabbit anti-muc2 abx177613
    Primary Antibody Rabbit Anti Muc2 Abx177613, supplied by Abbexa Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+rabbit+anti-muc2/human+muc2+elisa+kit+abx055282/pm38896938-68-29-32
    Average 90 stars, based on 1 article reviews
    primary antibody rabbit anti-muc2 abx177613 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Beyotime clonal rabbit anti-mouse primary antibody (muc2)
    Clonal Rabbit Anti Mouse Primary Antibody (Muc2), supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+rabbit+anti-muc2/rabbit+anti+muc2+antibody/pm37764783-92-8-15
    Average 90 stars, based on 1 article reviews
    clonal rabbit anti-mouse primary antibody (muc2) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    93
    Boster Bio rabbit anti muc2 primary antibody
    Figure 3. Biochemical analysis of the GI mucus obtained from the rat model of sporadic AD induced by intracerebroventricular streptozotocin (STZ-icv) and the controls. (A) UV−vis spectra of mucus from the control and the STZ-icv animals (left) and the area under the curve reflecting dilution (right). (B) Absorbance of samples at 230, 260, and 280 nm, reflecting the concentration of salts, nucleic acids, and proteins. (C) Relationship between sample absorbance (log-transformed y-axis) and wavelength depicted for the demonstration of the relationship between the 400 nm peak and the UV region. (D) Model-derived estimates from the linear model reflecting the concentration of protein in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (E) Model-derived estimates from the linear model reflecting the signal intensity of AB; reflecting glycoprotein content) in the mucus of the STZ- icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (F) <t>Mucin</t> <t>2</t> <t>(MUC2)</t> dot blot, model-derived estimates from the linear model reflecting the concentration of MUC2 in the mucus of the STZ-icv and the controls (left) and the contrast illustrating the effect size (right). Mean estimates are accompanied by 95% confidence intervals. (G) Model- derived estimates from the linear model reflecting peak mastPASTA-obtained force (inversely correlated with lubrication capacity) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (H) Model-derived estimates from the linear model reflecting the oxidation−reduction potential (ORP) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (I) Model- derived estimates from the linear model reflecting the NRP-integrated density in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (J) Model-derived estimates from the linear model reflecting the 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS)-derived reductive capacity (in equivalents of dithiothreitol [mM]) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (J) Model-derived estimates from the linear model reflecting lipid peroxidation (estimated using the thiobarbituric acid reactive substances (TBARS) assay) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals.
    Rabbit Anti Muc2 Primary Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+rabbit+anti-muc2/Anti-MUC2+Antibody/pm37477640-207-6-10
    Average 93 stars, based on 1 article reviews
    rabbit anti muc2 primary antibody - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology primary antibodies rabbit monoclonal anti-muc2
    Figure 3. Biochemical analysis of the GI mucus obtained from the rat model of sporadic AD induced by intracerebroventricular streptozotocin (STZ-icv) and the controls. (A) UV−vis spectra of mucus from the control and the STZ-icv animals (left) and the area under the curve reflecting dilution (right). (B) Absorbance of samples at 230, 260, and 280 nm, reflecting the concentration of salts, nucleic acids, and proteins. (C) Relationship between sample absorbance (log-transformed y-axis) and wavelength depicted for the demonstration of the relationship between the 400 nm peak and the UV region. (D) Model-derived estimates from the linear model reflecting the concentration of protein in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (E) Model-derived estimates from the linear model reflecting the signal intensity of AB; reflecting glycoprotein content) in the mucus of the STZ- icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (F) <t>Mucin</t> <t>2</t> <t>(MUC2)</t> dot blot, model-derived estimates from the linear model reflecting the concentration of MUC2 in the mucus of the STZ-icv and the controls (left) and the contrast illustrating the effect size (right). Mean estimates are accompanied by 95% confidence intervals. (G) Model- derived estimates from the linear model reflecting peak mastPASTA-obtained force (inversely correlated with lubrication capacity) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (H) Model-derived estimates from the linear model reflecting the oxidation−reduction potential (ORP) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (I) Model- derived estimates from the linear model reflecting the NRP-integrated density in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (J) Model-derived estimates from the linear model reflecting the 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS)-derived reductive capacity (in equivalents of dithiothreitol [mM]) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (J) Model-derived estimates from the linear model reflecting lipid peroxidation (estimated using the thiobarbituric acid reactive substances (TBARS) assay) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals.
    Primary Antibodies Rabbit Monoclonal Anti Muc2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+rabbit+anti-muc2/anti+gr/pm36603529-149-9-13
    Average 90 stars, based on 1 article reviews
    primary antibodies rabbit monoclonal anti-muc2 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    96
    Santa Cruz Biotechnology primary antibody rabbit anti muc2
    Figure 3. Biochemical analysis of the GI mucus obtained from the rat model of sporadic AD induced by intracerebroventricular streptozotocin (STZ-icv) and the controls. (A) UV−vis spectra of mucus from the control and the STZ-icv animals (left) and the area under the curve reflecting dilution (right). (B) Absorbance of samples at 230, 260, and 280 nm, reflecting the concentration of salts, nucleic acids, and proteins. (C) Relationship between sample absorbance (log-transformed y-axis) and wavelength depicted for the demonstration of the relationship between the 400 nm peak and the UV region. (D) Model-derived estimates from the linear model reflecting the concentration of protein in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (E) Model-derived estimates from the linear model reflecting the signal intensity of AB; reflecting glycoprotein content) in the mucus of the STZ- icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (F) <t>Mucin</t> <t>2</t> <t>(MUC2)</t> dot blot, model-derived estimates from the linear model reflecting the concentration of MUC2 in the mucus of the STZ-icv and the controls (left) and the contrast illustrating the effect size (right). Mean estimates are accompanied by 95% confidence intervals. (G) Model- derived estimates from the linear model reflecting peak mastPASTA-obtained force (inversely correlated with lubrication capacity) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (H) Model-derived estimates from the linear model reflecting the oxidation−reduction potential (ORP) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (I) Model- derived estimates from the linear model reflecting the NRP-integrated density in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (J) Model-derived estimates from the linear model reflecting the 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS)-derived reductive capacity (in equivalents of dithiothreitol [mM]) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (J) Model-derived estimates from the linear model reflecting lipid peroxidation (estimated using the thiobarbituric acid reactive substances (TBARS) assay) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals.
    Primary Antibody Rabbit Anti Muc2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+rabbit+anti-muc2/Mucin+2+Antibody/pmc08593611-226-0-4
    Average 96 stars, based on 1 article reviews
    primary antibody rabbit anti muc2 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology primary antibody rabbit monoclonal anti-muc2
    Figure 3. Biochemical analysis of the GI mucus obtained from the rat model of sporadic AD induced by intracerebroventricular streptozotocin (STZ-icv) and the controls. (A) UV−vis spectra of mucus from the control and the STZ-icv animals (left) and the area under the curve reflecting dilution (right). (B) Absorbance of samples at 230, 260, and 280 nm, reflecting the concentration of salts, nucleic acids, and proteins. (C) Relationship between sample absorbance (log-transformed y-axis) and wavelength depicted for the demonstration of the relationship between the 400 nm peak and the UV region. (D) Model-derived estimates from the linear model reflecting the concentration of protein in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (E) Model-derived estimates from the linear model reflecting the signal intensity of AB; reflecting glycoprotein content) in the mucus of the STZ- icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (F) <t>Mucin</t> <t>2</t> <t>(MUC2)</t> dot blot, model-derived estimates from the linear model reflecting the concentration of MUC2 in the mucus of the STZ-icv and the controls (left) and the contrast illustrating the effect size (right). Mean estimates are accompanied by 95% confidence intervals. (G) Model- derived estimates from the linear model reflecting peak mastPASTA-obtained force (inversely correlated with lubrication capacity) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (H) Model-derived estimates from the linear model reflecting the oxidation−reduction potential (ORP) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (I) Model- derived estimates from the linear model reflecting the NRP-integrated density in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (J) Model-derived estimates from the linear model reflecting the 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS)-derived reductive capacity (in equivalents of dithiothreitol [mM]) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (J) Model-derived estimates from the linear model reflecting lipid peroxidation (estimated using the thiobarbituric acid reactive substances (TBARS) assay) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals.
    Primary Antibody Rabbit Monoclonal Anti Muc2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+rabbit+anti-muc2/anti+gr/pmc08724542-96-13-16
    Average 90 stars, based on 1 article reviews
    primary antibody rabbit monoclonal anti-muc2 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Biorbyt primary antibody rabbit anti-muc2
    Figure 3. Biochemical analysis of the GI mucus obtained from the rat model of sporadic AD induced by intracerebroventricular streptozotocin (STZ-icv) and the controls. (A) UV−vis spectra of mucus from the control and the STZ-icv animals (left) and the area under the curve reflecting dilution (right). (B) Absorbance of samples at 230, 260, and 280 nm, reflecting the concentration of salts, nucleic acids, and proteins. (C) Relationship between sample absorbance (log-transformed y-axis) and wavelength depicted for the demonstration of the relationship between the 400 nm peak and the UV region. (D) Model-derived estimates from the linear model reflecting the concentration of protein in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (E) Model-derived estimates from the linear model reflecting the signal intensity of AB; reflecting glycoprotein content) in the mucus of the STZ- icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (F) <t>Mucin</t> <t>2</t> <t>(MUC2)</t> dot blot, model-derived estimates from the linear model reflecting the concentration of MUC2 in the mucus of the STZ-icv and the controls (left) and the contrast illustrating the effect size (right). Mean estimates are accompanied by 95% confidence intervals. (G) Model- derived estimates from the linear model reflecting peak mastPASTA-obtained force (inversely correlated with lubrication capacity) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (H) Model-derived estimates from the linear model reflecting the oxidation−reduction potential (ORP) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (I) Model- derived estimates from the linear model reflecting the NRP-integrated density in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (J) Model-derived estimates from the linear model reflecting the 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS)-derived reductive capacity (in equivalents of dithiothreitol [mM]) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (J) Model-derived estimates from the linear model reflecting lipid peroxidation (estimated using the thiobarbituric acid reactive substances (TBARS) assay) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals.
    Primary Antibody Rabbit Anti Muc2, supplied by Biorbyt, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+rabbit+anti-muc2/muc2+antibody+orb547659/pmc08714829-81-9-11
    Average 90 stars, based on 1 article reviews
    primary antibody rabbit anti-muc2 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology primary rabbit anti-muc2
    Figure 3. Biochemical analysis of the GI mucus obtained from the rat model of sporadic AD induced by intracerebroventricular streptozotocin (STZ-icv) and the controls. (A) UV−vis spectra of mucus from the control and the STZ-icv animals (left) and the area under the curve reflecting dilution (right). (B) Absorbance of samples at 230, 260, and 280 nm, reflecting the concentration of salts, nucleic acids, and proteins. (C) Relationship between sample absorbance (log-transformed y-axis) and wavelength depicted for the demonstration of the relationship between the 400 nm peak and the UV region. (D) Model-derived estimates from the linear model reflecting the concentration of protein in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (E) Model-derived estimates from the linear model reflecting the signal intensity of AB; reflecting glycoprotein content) in the mucus of the STZ- icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (F) <t>Mucin</t> <t>2</t> <t>(MUC2)</t> dot blot, model-derived estimates from the linear model reflecting the concentration of MUC2 in the mucus of the STZ-icv and the controls (left) and the contrast illustrating the effect size (right). Mean estimates are accompanied by 95% confidence intervals. (G) Model- derived estimates from the linear model reflecting peak mastPASTA-obtained force (inversely correlated with lubrication capacity) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (H) Model-derived estimates from the linear model reflecting the oxidation−reduction potential (ORP) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (I) Model- derived estimates from the linear model reflecting the NRP-integrated density in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (J) Model-derived estimates from the linear model reflecting the 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS)-derived reductive capacity (in equivalents of dithiothreitol [mM]) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (J) Model-derived estimates from the linear model reflecting lipid peroxidation (estimated using the thiobarbituric acid reactive substances (TBARS) assay) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals.
    Primary Rabbit Anti Muc2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/primary+rabbit+anti-muc2/anti+gr/pmc07291859-94-7-9
    Average 90 stars, based on 1 article reviews
    primary rabbit anti-muc2 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Figure 3. Biochemical analysis of the GI mucus obtained from the rat model of sporadic AD induced by intracerebroventricular streptozotocin (STZ-icv) and the controls. (A) UV−vis spectra of mucus from the control and the STZ-icv animals (left) and the area under the curve reflecting dilution (right). (B) Absorbance of samples at 230, 260, and 280 nm, reflecting the concentration of salts, nucleic acids, and proteins. (C) Relationship between sample absorbance (log-transformed y-axis) and wavelength depicted for the demonstration of the relationship between the 400 nm peak and the UV region. (D) Model-derived estimates from the linear model reflecting the concentration of protein in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (E) Model-derived estimates from the linear model reflecting the signal intensity of AB; reflecting glycoprotein content) in the mucus of the STZ- icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (F) Mucin 2 (MUC2) dot blot, model-derived estimates from the linear model reflecting the concentration of MUC2 in the mucus of the STZ-icv and the controls (left) and the contrast illustrating the effect size (right). Mean estimates are accompanied by 95% confidence intervals. (G) Model- derived estimates from the linear model reflecting peak mastPASTA-obtained force (inversely correlated with lubrication capacity) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (H) Model-derived estimates from the linear model reflecting the oxidation−reduction potential (ORP) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (I) Model- derived estimates from the linear model reflecting the NRP-integrated density in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (J) Model-derived estimates from the linear model reflecting the 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS)-derived reductive capacity (in equivalents of dithiothreitol [mM]) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (J) Model-derived estimates from the linear model reflecting lipid peroxidation (estimated using the thiobarbituric acid reactive substances (TBARS) assay) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals.

    Journal: ACS chemical neuroscience

    Article Title: Altered Secretion, Constitution, and Functional Properties of the Gastrointestinal Mucus in a Rat Model of Sporadic Alzheimer's Disease.

    doi: 10.1021/acschemneuro.3c00223

    Figure Lengend Snippet: Figure 3. Biochemical analysis of the GI mucus obtained from the rat model of sporadic AD induced by intracerebroventricular streptozotocin (STZ-icv) and the controls. (A) UV−vis spectra of mucus from the control and the STZ-icv animals (left) and the area under the curve reflecting dilution (right). (B) Absorbance of samples at 230, 260, and 280 nm, reflecting the concentration of salts, nucleic acids, and proteins. (C) Relationship between sample absorbance (log-transformed y-axis) and wavelength depicted for the demonstration of the relationship between the 400 nm peak and the UV region. (D) Model-derived estimates from the linear model reflecting the concentration of protein in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (E) Model-derived estimates from the linear model reflecting the signal intensity of AB; reflecting glycoprotein content) in the mucus of the STZ- icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (F) Mucin 2 (MUC2) dot blot, model-derived estimates from the linear model reflecting the concentration of MUC2 in the mucus of the STZ-icv and the controls (left) and the contrast illustrating the effect size (right). Mean estimates are accompanied by 95% confidence intervals. (G) Model- derived estimates from the linear model reflecting peak mastPASTA-obtained force (inversely correlated with lubrication capacity) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (H) Model-derived estimates from the linear model reflecting the oxidation−reduction potential (ORP) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (I) Model- derived estimates from the linear model reflecting the NRP-integrated density in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (J) Model-derived estimates from the linear model reflecting the 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS)-derived reductive capacity (in equivalents of dithiothreitol [mM]) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals. (J) Model-derived estimates from the linear model reflecting lipid peroxidation (estimated using the thiobarbituric acid reactive substances (TBARS) assay) in the mucus of the STZ-icv and the controls (upper) and the contrast illustrating the effect size (lower). Mean estimates are accompanied by 95% confidence intervals.

    Article Snippet: Blocked membranes were incubated with the rabbit anti-MUC2 primary antibody (Boster Biological Technology, USA) diluted in the blocking buffer 500-fold for 24 h at 4 °C.

    Techniques: Control, Concentration Assay, Transformation Assay, Derivative Assay, Dot Blot, TBARS Assay